235 related articles for article (PubMed ID: 32074080)
1. Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer.
Chen P; Yang Y; Zhang Y; Jiang S; Li X; Wan J
Aging (Albany NY); 2020 Feb; 12(4):3371-3387. PubMed ID: 32074080
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of the Relationship between Cuproptosis-Related Gene GCSH and Prognosis, Tumor Microenvironment Infiltration, and Therapy Response in Endometrial Cancer.
Zhao M; Nie H; Qiu P; Yu Y; Wang H; Wang F; Fang J; Zhao Q
Oncology; 2024; 102(5):368-381. PubMed ID: 37827132
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a nine-gene prognostic model for predicting overall survival of patients with endometrial carcinoma.
Ying J; Wang Q; Xu T; Lyu J
Cancer Med; 2018 Jun; 7(6):2601-2611. PubMed ID: 29665298
[TBL] [Abstract][Full Text] [Related]
4. Glycometabolism and lipid metabolism related genes predict the prognosis of endometrial carcinoma and their effects on tumor cells.
Lin X; Zheng J; Cai X; Liu L; Jiang S; Liu Q; Sun Y
BMC Cancer; 2024 May; 24(1):571. PubMed ID: 38720279
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of ESPL1 is associated with poor prognostic outcomes in endometrial cancer.
Yang Y; Sheng Y; Zheng J; Ma A; Chen S; Lin J; Yang X; Liang Y; Zhang Y; Zheng X
Biomarkers; 2024 Jun; 29(4):185-193. PubMed ID: 38568742
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid metabolism is related to the immune microenvironment changes of gastric cancer and RGS2 is a new tumor biomarker.
Yang S; Sun B; Li W; Yang H; Li N; Zhang X
Front Immunol; 2022; 13():1065927. PubMed ID: 36591293
[TBL] [Abstract][Full Text] [Related]
7. Identification of the prognostic immune subtype in copy-number high endometrial cancer.
Mao M; Jiang F; Han R; Xiang Y
J Gynecol Oncol; 2024 Jan; 35(1):e8. PubMed ID: 37857563
[TBL] [Abstract][Full Text] [Related]
8. Discovery of the potential biomarkers for early diagnosis of endometrial cancer via integrating metabolomics and transcriptomics.
Fu Y; Wang C; Wu Z; Zhang X; Liu Y; Wang X; Liu F; Chen Y; Zhang Y; Zhao H; Wang Q
Comput Biol Med; 2024 May; 173():108327. PubMed ID: 38552279
[TBL] [Abstract][Full Text] [Related]
9. Exploration of the Correlation Between
Guo S; Bai W; Cui F; Chen X; Fang X; Shen H; Gu X
Pharmgenomics Pers Med; 2024; 17():91-103. PubMed ID: 38586176
[TBL] [Abstract][Full Text] [Related]
10. A radiogenomics application for prognostic profiling of endometrial cancer.
Hoivik EA; Hodneland E; Dybvik JA; Wagner-Larsen KS; Fasmer KE; Berg HF; Halle MK; Haldorsen IS; Krakstad C
Commun Biol; 2021 Dec; 4(1):1363. PubMed ID: 34873276
[TBL] [Abstract][Full Text] [Related]
11. Unraveling Endometrial Cancer Survival Predictors Through Advanced Machine Learning Techniques.
Kopanitsa G; Metsker O
Stud Health Technol Inform; 2024 May; 314():127-131. PubMed ID: 38785018
[TBL] [Abstract][Full Text] [Related]
12. Combining the prognostic role of age with molecular advances in the understanding of endometrial cancer.
Senguttuvan RN; Cohen JG
Lancet Oncol; 2024 Jun; 25(6):688-690. PubMed ID: 38701814
[No Abstract] [Full Text] [Related]
13. A pan-cancer fingerprint: common molecular denominators of the human tumor microenvironment.
Ng SS; Leonardelli S; Hölzel M
Signal Transduct Target Ther; 2021 Nov; 6(1):394. PubMed ID: 34764260
[No Abstract] [Full Text] [Related]
14. Prognostic significance of immune landscape in tumour microenvironment of endometrial cancer.
Li BL; Wan XP
J Cell Mol Med; 2020 Jul; 24(14):7767-7777. PubMed ID: 32424934
[TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic and immune-related gene signatures in the tumor microenvironment of endometrial cancer.
Wang G; Wang D; Sun M; Liu X; Yang Q
Int Immunopharmacol; 2020 Nov; 88():106931. PubMed ID: 32889237
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel prognosis-related genes in the endometrial cancer immune microenvironment.
Ma J; Zhang JK; Yang D; Ma XX
Aging (Albany NY); 2020 Nov; 12(21):22152-22173. PubMed ID: 33159014
[TBL] [Abstract][Full Text] [Related]
17. Endometrial Cancer.
Lu KH; Broaddus RR
N Engl J Med; 2020 Nov; 383(21):2053-2064. PubMed ID: 33207095
[No Abstract] [Full Text] [Related]
18. Screening and Identification of Prognostic Tumor-Infiltrating Immune Cells and Genes of Endometrioid Endometrial Adenocarcinoma: Based on The Cancer Genome Atlas Database and Bioinformatics.
Chen B; Wang D; Li J; Hou Y; Qiao C
Front Oncol; 2020; 10():554214. PubMed ID: 33335850
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Implications of Immune-Related Genes' (IRGs) Signature Models in Cervical Cancer and Endometrial Cancer.
Ding H; Fan GL; Yi YX; Zhang W; Xiong XX; Mahgoub OK
Front Genet; 2020; 11():725. PubMed ID: 32793281
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of tumor mutation burden and immune infiltrates in endometrial cancer.
Zhou H; Chen L; Lei Y; Li T; Li H; Cheng X
Curr Probl Cancer; 2021 Apr; 45(2):100660. PubMed ID: 33012523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
